Ethnic sensitivity analyses of pharmacokinetics, efficacy and safety in polycythemia vera treatment with ropeginterferon alfa-2b
Ropeginterferon alfa-2b (Ropeg) is approved for the treatment of adults with polycythemia vera (PV).This report aims to analyze the ethnic sensitivity of Ropeg for the treatment of PV, comparing the pharmacokinetics (PK), efficacy, and safety profiles across diverse ethnic groups.We conducted a relevant review of PV and analysis of data obtained fr